TLRY vs. BHC, AUP, CARA, CRON, SLS, TEV, ABT, NOT, PYR, and NVO
Should you be buying Tilray Brands stock or one of its competitors? The main competitors of Tilray Brands include Bausch Health Companies (BHC), Aurinia Pharmaceuticals (AUP), Cara Operations (CARA), Cronos Group (CRON), Solaris Resources (SLS), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), and Novo Resources Corp. (NVO.V) (NVO). These companies are all part of the "pharmaceutical products" industry.
Tilray Brands vs. Its Competitors
Bausch Health Companies (TSE:BHC) and Tilray Brands (TSE:TLRY) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, analyst recommendations, institutional ownership and risk.
Bausch Health Companies has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 2.19, suggesting that its share price is 119% more volatile than the S&P 500.
In the previous week, Bausch Health Companies had 6 more articles in the media than Tilray Brands. MarketBeat recorded 14 mentions for Bausch Health Companies and 8 mentions for Tilray Brands. Tilray Brands' average media sentiment score of 0.19 beat Bausch Health Companies' score of -0.06 indicating that Tilray Brands is being referred to more favorably in the news media.
79.0% of Bausch Health Companies shares are held by institutional investors. Comparatively, 11.2% of Tilray Brands shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by company insiders. Comparatively, 0.7% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Bausch Health Companies has higher revenue and earnings than Tilray Brands. Bausch Health Companies is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.
Bausch Health Companies has a net margin of -1.88% compared to Tilray Brands' net margin of -30.02%. Bausch Health Companies' return on equity of 15.87% beat Tilray Brands' return on equity.
Summary
Bausch Health Companies beats Tilray Brands on 9 of the 14 factors compared between the two stocks.
Get Tilray Brands News Delivered to You Automatically
Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Tilray Brands Competitors List
Related Companies and Tools
This page (TSE:TLRY) was last updated on 8/25/2025 by MarketBeat.com Staff
MarketBeat All Access